ANHUI MENOVO （NINGBO MENOVO）

Founded in 2004 and headquartered in Ningbo cily, Zheiang Province. Ningho Menovo Pharmaceutical Co.Ltd. was listed on the main board of SSE on April 7,2017,stock abbreviation: Menovo, stock code 603538. The company is a comprehensive international pharmaceutical technology manufacturing enterprise specializing in the development, production and sales of specialty APls (including intermediates)and formulations, with CDMO, specially APls, formulation integration business as the main development core. service coverage of global mainstream countries and regions, core products covering cardiovascular, central nervous system, antiviral, hypoglycemic, gastrointestinal and digestive tract and other therapeutic areas, to provide domestic and foreign partners with efficient, high-quality and cost-competitive products, services and solutions. At present, Menovo is in the key stage of rapid expansion of revenue scale, business structural adjustment and production capacity regional layout of the initial results, the company in further strengthening the existing industrial chain advantages, international compliance system advantages and regional coordination layout advantages, while accelerating the construction of the Group platform, enriching the type of products, and promote the outward growth. The company always upholds the business philosophy of healthy and sustainable development enterprise, deeply cultivates the business segments, and strives to become a global leading pharmaceutical company as soon as possible.